A related editorial notes that the optimal nitrofurantoin dosing regimen and whether current recommendations of 100 mg twice daily (licensed dose) are equally effective as 100 mg 3 times daily (dose used in trial) remains unknown. The role of fosfomycin also requires examination; in particular alternative prescribing practices for multidrug-resistant uropathogens should be investigated.